Alnylam Pharmaceuticals Inc
ALNY452.222USD
+10.522+2.38%
Market hours （ET）Quotes delayed by 15 min
59.60BMarket Cap
1368.04P/E TTM
Alnylam Pharmaceuticals Inc Earnings Date
Period
FY2025Q3 Earnings Date
Revenue(YoY)
1.25B
149.35%
EPS(YoY)
1.91
320.15%
Analyst Rating
BUY
2025-11-11
Financial Indicators
EPS
Revenue
Net Profit
Net Margin
Gross Margin
Debt to assets ratio
ROE
ROA
No Data
Income Statement
Revenue
Operating profit
Net Profit
No Data
Balance Sheet
Current assets
Total current liabilities
Total assets
Total liabilities
Total equity
No Data
Cash Flow Statement
Net operating income
Net investment
Net financing
No Data
